A correction needs to be made as I stated a 300% plus success rate above the baseline of chemo alone (15% pathological response)
The correct response increase is 230% plus above baseline, my bad
An acknowledgment goes out to our CSO (Said Sebti) not only for proof of concept but furthermore proof of functionality and future wishes of proof of application. As the inventor of both PTX200 and PTX100, Dr Sebti's inspirational advancement to science is a credit.
Wishing our CSO both peer acknowledgement and material gain alike.
Finally having the time to review the material realeased to the market, totally agree with our CEO (Steven) that of exciting times ahead for PTX...., needless to say, back to accumulating it is for me
Ann: Successful Completion of Phase 1b Breast Cancer Trial, page-20
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 29629 | 1 |
View Market Depth
| Last trade - 07.01am 20/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |
Day chart unavailable
